Medicis Pharmaceutical Corporation
http://www.medicis.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Medicis Pharmaceutical Corporation
Deal Watch: Vanda Gets Competing Offer From Cycle After Unsolicited Future Pak Bid
Plus deals involving GSK/Elsie, Lilly/QurAlis, Gilead/Cartography as well as tech transfer announcements and deals in brief.
InflaRx Undaunted By Dermatology Rivals
The group says INF904 can make billions in two highly competitive skin diseases, but this looks optimistic.
Rezo’s Platform Could ‘Fundamentally Shift’ Drug Discovery
Rezo’s chief technology officer Sourav Bandyopadhyay discusses the company's focus on leveraging AI and machine learning to accelerate drug discovery and its potential for partnerships with big pharma.
Astellas Rejigs R&D Focus Areas As It Withdraws From Mitochondria R&D
As Astellas pivots through several candidates in an attempt to create its next blockbuster, a decision to terminate its only prospect in the core mitochondrial R&D area leaves very few other competitors in the market.
Company Information
- Industry
-
Pharmaceuticals
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
-
- Graceway Pharmaceuticals, LLC
- Ucyclyd Pharma, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice